(PNNT) PennantPark Investment - Ratings and Ratios
Mezzanine Debt, Senior Loans, Equity Co-Investments, Middle-Market
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 15.82% |
| Yield on Cost 5y | 38.25% |
| Yield CAGR 5y | 13.94% |
| Payout Consistency | 94.0% |
| Payout Ratio | 45.1% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 24.7% |
| Value at Risk 5%th | 40.9% |
| Relative Tail Risk | 0.61% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.01 |
| Alpha | -11.33 |
| CAGR/Max DD | 0.69 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.341 |
| Beta | 0.669 |
| Beta Downside | 0.679 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.14% |
| Mean DD | 5.34% |
| Median DD | 4.44% |
Description: PNNT PennantPark Investment October 25, 2025
PennantPark Investment Corporation (NYSE:PNNT) is a Business Development Company that provides private-equity style financing to U.S. middle-market companies, primarily through mezzanine debt, senior secured loans, and equity-linked instruments.
The fund targets investments of $10 million to $100 million across the capital structure, focusing on companies with EBITDA between $10 million and $50 million. Typical loan sizes range from $15 million to $50 million, and the BDC may also take non-control equity positions or co-invest alongside other private-equity partners.
As of the most recent filing, PNNT reported assets under management of roughly $1.2 billion, a net asset value (NAV) per share of $10.5, and a dividend yield near 9%. Its portfolio is weighted about 60% toward mezzanine debt, 30% senior secured loans, and 10% equity-related investments, reflecting a diversified exposure across sectors such as technology, healthcare, and energy.
Key drivers for PNNT’s performance include the health of the U.S. middle-market credit market-where tighter spreads can pressure yields-and macro-economic trends like sustained GDP growth and robust M&A activity that fuel demand for flexible financing solutions, especially in high-growth tech and healthcare sub-sectors.
For a deeper quantitative assessment, you may want to explore ValueRay’s analytics platform, which offers granular, real-time metrics on BDC fundamentals and sector-specific risk factors.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (32.7m TTM) > 0 and > 6% of Revenue (6% = 6.04m TTM) |
| FCFTA 0.17 (>2.0%) and ΔFCFTA 27.85pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -89.01% (prev -47.80%; Δ -41.21pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.17 (>3.0%) and CFO 229.8m > Net Income 32.7m (YES >=105%, WARN >=100%) |
| Net Debt (687.1m) to EBITDA (77.0m) ratio: 8.93 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.39 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (65.3m) change vs 12m ago -0.22% (target <= -2.0% for YES) |
| Gross Margin 62.48% (prev 65.96%; Δ -3.48pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 7.36% (prev 8.24%; Δ -0.89pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.00 (EBITDA TTM 77.0m / Interest Expense TTM 10.09b) >= 6 (WARN >= 3) |
Altman Z'' -1.29
| (A) -0.07 = (Total Current Assets 57.0m - Total Current Liabilities 146.7m) / Total Assets 1.35b |
| (B) -0.20 = Retained Earnings (Balance) -276.6m / Total Assets 1.35b |
| (C) 0.02 = EBIT TTM 28.7m / Avg Total Assets 1.37b |
| (D) -0.31 = Book Value of Equity -276.6m / Total Liabilities 885.6m |
| Total Rating: -1.29 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 54.94
| 1. Piotroski 4.50pt |
| 2. FCF Yield 21.23% |
| 3. FCF Margin data missing |
| 4. Debt/Equity 1.59 |
| 5. Debt/Ebitda 8.93 |
| 6. ROIC - WACC (= -0.47)% |
| 7. RoE 6.79% |
| 8. Rev. Trend 18.25% |
| 9. EPS Trend 4.68% |
What is the price of PNNT shares?
Over the past week, the price has changed by -3.80%, over one month by -7.02%, over three months by -12.61% and over the past year by +3.13%.
Is PNNT a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 6
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the PNNT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 6.2 | 1.3% |
| Analysts Target Price | 6.2 | 1.3% |
| ValueRay Target Price | 7.4 | 21.3% |
PNNT Fundamental Data Overview November 29, 2025
P/E Trailing = 7.575
P/E Forward = 9.2507
P/S = 3.2334
P/B = 0.8234
P/EG = 0.279
Beta = 0.63
Revenue TTM = 100.7m USD
EBIT TTM = 28.7m USD
EBITDA TTM = 77.0m USD
Long Term Debt = unknown (none)
Short Term Debt = 149.5m USD (from shortTermDebt, last fiscal year)
Debt = 738.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 687.1m USD (from netDebt column, last quarter)
Enterprise Value = 1.08b USD (395.7m + Debt 738.9m - CCE 51.8m)
Interest Coverage Ratio = 0.00 (Ebit TTM 28.7m / Interest Expense TTM 10.09b)
FCF Yield = 21.23% (FCF TTM 229.8m / Enterprise Value 1.08b)
FCF Margin = 228.1% (FCF TTM 229.8m / Revenue TTM 100.7m)
Net Margin = 32.48% (Net Income TTM 32.7m / Revenue TTM 100.7m)
Gross Margin = 62.48% ((Revenue TTM 100.7m - Cost of Revenue TTM 37.8m) / Revenue TTM)
Gross Margin QoQ = -3.51% (prev 68.89%)
Tobins Q-Ratio = 0.80 (Enterprise Value 1.08b / Total Assets 1.35b)
Interest Expense / Debt = 1362 % (Interest Expense 10.06b / Debt 738.9m)
Taxrate = -210.9% (out of range, set to none) (620.0k / -294.0k)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 0.39 (Total Current Assets 57.0m / Total Current Liabilities 146.7m)
Debt / Equity = 1.59 (Debt 738.9m / totalStockholderEquity, last quarter 463.9m)
Debt / EBITDA = 8.93 (Net Debt 687.1m / EBITDA 77.0m)
Debt / FCF = 2.99 (Net Debt 687.1m / FCF TTM 229.8m)
Total Stockholder Equity = 481.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.42% (Net Income 32.7m / Total Assets 1.35b)
RoE = 6.79% (Net Income TTM 32.7m / Total Stockholder Equity 481.7m)
RoCE = 2.38% (EBIT 28.7m / Capital Employed (Total Assets 1.35b - Current Liab 146.7m))
RoIC = 2.49% (EBIT 28.7m / (Assets 1.35b - Curr.Liab 146.7m - Cash 51.8m))
WACC = 2.96% (E(395.7m)/V(1.13b) * Re(8.48%) + (debt cost/tax rate unavailable))
Discount Rate = 8.48% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 0.05%
[DCF Debug] Terminal Value 68.51% ; FCFE base≈229.8m ; Y1≈150.9m ; Y5≈69.0m
Fair Price DCF = 19.30 (DCF Value 1.26b / Shares Outstanding 65.3m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 4.68 | EPS CAGR: -6.11% | SUE: -1.37 | # QB: 0
Revenue Correlation: 18.25 | Revenue CAGR: -35.85% | SUE: -4.0 | # QB: 0
Additional Sources for PNNT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle